Neoreviews
HOME HELP CONTACT US SUBSCRIPTIONS CME ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Take the CME quiz:
Vol. 8 No. 3, March 2007
Right arrow E-Letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-Letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jonas, J. M.
Right arrow Articles by Demmer, L. A.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Jonas, J. M.
Right arrow Articles by Demmer, L. A.

NeoReviews Vol.8 No.3 2007 e120
© 2007 American Academy of Pediatrics

Genetic Syndromes Determined by Alterations in Genomic Imprinting Pathways

Jessica M. Jonas, MS, CGC*
Laurie A. Demmer, MD*

* Division of Genetics, Department of Pediatrics, Tufts-New England Medical Center, Boston, Mass

Genomic imprinting appears to be a mammal-specific phenomenon whereby differential gene expression according to parent of origin has evolved as a means to regulate many complex pathways related to growth, metabolism, and neurologic development. Imprinting is accomplished by an epigenetic mechanism involving, for example, methylation of specific sequences, without changing the underlying genetic code. This process occurs with very specific timing in relation to development of an embryo and is reset in the sex-specific gametes of each individual. Epigenetic deregulation of the imprinting process is the cause of specific genetic syndromes, many of which show alterations in growth, metabolism, and neurologic development. In fact, it has been demonstrated that alterations of a single imprinting control region (IGF2/H19) can lead to opposite disorders of congenital growth (Beckwith-Wiedemann syndrome and Silver-Russell syndrome). Recently, it has been suggested that the use of assisted reproductive techniques such as in vitro fertilization may heighten the susceptibility of embryos to epigenetic deregulation, leading to increased risk for certain imprinting disorders. Also, the knowledge that imprinted genes are involved in pathways of fetal and placental growth has prompted researchers to look into the role of imprinting in intrauterine growth restriction. This may have consequences well beyond the newborn period because epidemiologic studies have shown a strong link between poor fetal growth and the susceptibility to glucose intolerance and insulin resistance syndrome in adults.

Abbreviations: AHO: Albright hereditary osteodystrophy • AS: Angelman syndrome • BWS: Beckwith-Wiedemann syndrome • ICR: imprinting control region • IUGR: intrauterine growth restriction • Mb: megabase • PWS: Prader-Willi syndrome • SRS: Silver-Russell syndrome • TNDM: transient neonatal diabetes mellitus • UPD: uniparental disomy




This article has been cited by other articles:


Home page
NeoReviewsHome page
N. Bishara and C. L. Clericuzio
Common Dysmorphic Syndromes in the NICU
NeoReviews, January 1, 2008; 9(1): e29 - e38.
[Abstract] [Full Text] [PDF]




HOME HELP CONTACT US SUBSCRIPTIONS CME ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by the American Academy of Pediatrics.